131 related articles for article (PubMed ID: 2077186)
1. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs.
Misawa M; Iwamura S
Jpn J Pharmacol; 1990 Oct; 54(2):217-26. PubMed ID: 2077186
[TBL] [Abstract][Full Text] [Related]
2. [Effect of platelet-activating factor on nasal vascular permeability and eosinophil accumulation in guinea pigs].
Shirasaki H; Asakura K
Nihon Jibiinkoka Gakkai Kaiho; 1990 Apr; 93(4):615-21. PubMed ID: 2376799
[TBL] [Abstract][Full Text] [Related]
3. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
4. The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis.
Albert DH; Malo PE; Tapang P; Shaughnessy TK; Morgan DW; Wegner CD; Curtin ML; Sheppard GS; Xu L; Davidsen SK; Summers JB; Carter GW
J Pharmacol Exp Ther; 1998 Jan; 284(1):83-8. PubMed ID: 9435164
[TBL] [Abstract][Full Text] [Related]
5. Effects of TMK688, a novel anti-allergic drug, on allergic nasal obstruction and exudative responses in sensitized guinea pigs.
Shizawa T; Maeda K; Abe K; Ishii T; Kamitani T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):815-9. PubMed ID: 9453468
[TBL] [Abstract][Full Text] [Related]
6. Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig.
Evans TW; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Clin Sci (Lond); 1989 May; 76(5):479-85. PubMed ID: 2721114
[TBL] [Abstract][Full Text] [Related]
7. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of a TP-receptor antagonist, S-1452, on antigen-induced nasal plasma exudation in guinea pig model for allergic rhinitis.
Yasui K; Asanuma F; Arimura A
Pharmacology; 2001; 63(2):65-70. PubMed ID: 11490197
[TBL] [Abstract][Full Text] [Related]
9. A new rhinitis model using chemical mediators in rats.
Misawa M
Jpn J Pharmacol; 1988 Sep; 48(1):15-22. PubMed ID: 3199605
[TBL] [Abstract][Full Text] [Related]
10. [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy].
Shirasaki H; Asakura K
Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar; 93(3):420-7. PubMed ID: 2352050
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
12. Effects of a specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs.
Fujita M; Yonetomi Y; Takeda H; Nakagawa N; Kawabata K; Ohno H
Jpn J Pharmacol; 1997 Dec; 75(4):347-53. PubMed ID: 9469640
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.
Rogers DF; Dijk S; Barnes PJ
Br J Pharmacol; 1990 Nov; 101(3):739-45. PubMed ID: 2076490
[TBL] [Abstract][Full Text] [Related]
14. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
15. [Effect of amlexanox on experimental allergic rhinitis in actively sensitized guinea pigs].
Ukai K; Atsushi ; Yuda ; Nonoyama T; Sakakura Y; Ahida Y
Arerugi; 1990 Jan; 39(1):54-8. PubMed ID: 2350243
[TBL] [Abstract][Full Text] [Related]
16. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
17. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
Stock EL; Roth SI; Kim ED; Walsh MK; Thamman R
Invest Ophthalmol Vis Sci; 1990 May; 31(5):987-92. PubMed ID: 2335460
[TBL] [Abstract][Full Text] [Related]
18. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model.
Tohda Y; Muraki M; Kubo H; Itoh M; Haraguchi R; Nakajima S; Fukuoka M
Respiration; 2001; 68(1):73-7. PubMed ID: 11223734
[TBL] [Abstract][Full Text] [Related]
19. Effect of vascular endothelial growth factor on nasal vascular permeability.
Matsune S; Ohori J; Yoshifuku K; Kurono Y
Laryngoscope; 2010 Apr; 120(4):844-8. PubMed ID: 20213656
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
